| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $4.6M | +8.6% | -32.7% |
| SG&A Expense | $3.6M | +4.5% | +5.6% |
| Operating Income | -$8.1M | -6.8% | +20.0% |
| Pre-tax Income | -$9.0M | +4.5% | +16.0% |
| Income Tax | $0 | — | — |
| Net Income | -$9.0M | +4.5% | +16.0% |
| EPS (Basic) | -$0.19 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.2M | -17.8% | -47.3% |
| Current Assets | $27.9M | -17.1% | -46.5% |
| Total Assets | $34.7M | -14.3% | -33.8% |
| Current Liabilities | $13.3M | +15.6% | -27.3% |
| Total Liabilities | $25.3M | +3.0% | -17.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.0M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $8.6M | — | — |
| Free Cash Flow | -$24.0M | — | — |
| +34.5% |
| EPS (Diluted) | -$0.19 | +9.5% | +34.5% |
| $9.5M |
| -40.8% |
| -57.0% |